Published on December 21, 2017
The landscape of myeloma care is constantly evolving with the development of new research and treatment. While advances in myeloma therapies are exciting and beneficial, some patients feel overwhelmed making treatment decisions between all the available options. Myeloma patient Jack Aiello leads a discussion with Dr. Robert Orlowski of The University of Texas MD Anderson Cancer Center and Dr. Noopur Raje of Massachusetts General Hospital Cancer Center as they help decipher which type of therapy is appropriate for different conditions. They also consider the role of a transplant amidst new medicines, and the impact they have on attaining minimal residual disease (MRD) or complete remission.
Produced by Patient Power in partnership with The University of Texas MD Anderson Cancer Center. We thank AbbVie Inc. and Takeda Oncology for their support.